https://www.selleckchem.com/pr....oducts/deoxycholic-a
0001). Patients requiring high-dose with concurrent tachycardia had higher mortality at T1; in the low-dose group tachycardia was not associated with mortality. Resolving tachycardia (from T1 to T24) was associated with lower mortality compared to patients where tachycardia persisted (27.8% vs 46.4%; p = 0.001). CONCLUSIONS Use of high-dose norepinephrine and concurrent tachycardia are associated with poor outcomes in septic shock. The tendency to engage in addictive behaviors has long been tied to the actions of th